DAIC

FEBRUARY 1, 2024

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. percent Compound Annual Growth Rate (CAGR).

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Peripheral Arterial Disease Stroke 104

DAIC

FEBRUARY 3, 2025

Roche has an unrivaled ability to provide access to testing at scale and is committed to advancing innovation in preventive cardiology. Tsimikas S and Marcovina S, Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week , J Am Coll Cardiol. 2022 Aug, 80 (9) 934946 Kronenberg F.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Cardiometabolic Health Congress

JULY 25, 2024

This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease.

Education 100

Education Innovation Risk Factors Obesity 100

Cardiometabolic Health Congress

OCTOBER 25, 2024

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64

CME Innovation Education Atherosclerosis 64

Circulation

JANUARY 15, 2024

Coronary artery calcification (CAC) accompanies the development of advanced atherosclerosis. These innovations may speed achieving the ultimate goal of providing noninvasively specific and clinically actionable information. Circulation, Volume 149, Issue 3 , Page 251-266, January 16, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103